Gulshan Kumar

Research and teaching interests

In the Schweizer Group, my research involves developing amphiphilic tobramycin and apramycin derivatives to enhance their synergy with β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.